4.7 Article

Plasma Concentrations of Isoniazid and Rifampin Are Decreased in Adult Pulmonary Tuberculosis Patients with Diabetes Mellitus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Pharmacokinetics of Rifampin in Peruvian Tuberculosis Patients with and without Comorbid Diabetes or HIV

Ana Requena-Mendez et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Article Pharmacology & Pharmacy

Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

Miroslav Dostalek et al.

CLINICAL PHARMACOKINETICS (2012)

Article Medicine, General & Internal

Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study

Claudia Caroline Dobler et al.

BMJ OPEN (2012)

Article Respiratory System

Therapeutic drug monitoring in the treatment of active tuberculosis

Aylin Babalik et al.

CANADIAN RESPIRATORY JOURNAL (2011)

Article Microbiology

Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes

Rovina Ruslami et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Public, Environmental & Occupational Health

Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis

C. S. Wang et al.

EPIDEMIOLOGY AND INFECTION (2009)

Article Infectious Diseases

Type 2 diabetes and multidrug-resistant tuberculosis

Susan P. Fisher-Hoch et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)

Article Public, Environmental & Occupational Health

Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence

Catherine R. Stevenson et al.

BMC PUBLIC HEALTH (2007)

Article Immunology

Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

Hanneke M. J. Nijland et al.

CLINICAL INFECTIOUS DISEASES (2006)